Fort Point Capital Partners LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 73 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Fort Point Capital Partners LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$125,000
-12.0%
156,100
+1.3%
0.06%
-17.9%
Q4 2016$142,000
+27.9%
154,100
+2.7%
0.08%
+56.0%
Q3 2016$111,000
-29.3%
150,100
+23.6%
0.05%
-34.2%
Q2 2016$157,000
-42.9%
121,400
-0.8%
0.08%
-45.7%
Q1 2016$275,000
-15.1%
122,400
+32.1%
0.14%
-15.2%
Q4 2015$324,00092,6540.16%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,595,484$5,710,0004.85%
Cypress Capital Management LLC (WY) 321,725$708,0000.74%
Noven Financial Group, Inc. 103,964$229,0000.12%
Transform Wealth, LLC 205,481$452,0000.08%
Cutter & CO Brokerage, Inc. 50,000$110,0000.04%
TRUSTCORE FINANCIAL SERVICES, LLC 44,500$98,0000.04%
GHP Investment Advisors, Inc. 100,000$220,0000.03%
BRIGHTON JONES LLC 85,555$188,0000.02%
Valeo Financial Advisors, LLC 330,000$155,0000.02%
TRUSTCORE FINANCIAL SERVICES, LLC 27,348$60,0000.02%
View complete list of AMPIO PHARMACEUTICALS INC shareholders